Victoria Wargon
- Genetics top 10%
- Estrogen and related hormone effects 10
-
- Cytokine Signaling Pathways and Interactions 5
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 2
-
- Bioactive Compounds and Antitumor Agents 1
-
- Endometrial and Cervical Cancer Treatments 2
-
- Epigenetics and DNA Methylation 2
- Cancer therapeutics and mechanisms 1
- Co-authors
- Claudia LanariAlfredo MolinoloSebastián GiulianelliPaola RojasLuísa A. HelgueroCaroline A. LambRocío SoldatiAlfredo A. Molinolo
- Cited by
- GeneticsOncologyCancer Research
- Partner nations
- ArgentinaUnited StatesSweden
In The Last Decade
Victoria Wargon
15 papers receiving 466 citations
Peers
Comparison fields: 5 of 66
- Genetics 238
- Oncology 213
- Cancer Research 84
- Toxicology 16
- Obstetrics and Gynecology 33
Countries citing papers authored by Victoria Wargon
This map shows the geographic impact of Victoria Wargon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Wargon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Wargon more than expected).
Fields of papers citing papers by Victoria Wargon
This network shows the impact of papers produced by Victoria Wargon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Wargon. The network helps show where Victoria Wargon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Victoria Wargon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 33 | |
| 2 | 2014 | 28 | |
| 3 | 2013 | 6 | |
| 4 | 2013 | 19 | |
| 5 | 2012 | 79 | |
| 6 | エストロゲン受容体αは,サイクリンD1/MYCプロモーターにおいてプロゲステロン受容体と相互作用することにより,プロゲスチン誘発乳房腫瘍増殖を媒介する | 2012 | 1 |
| 7 | 2012 | 68 | |
| 8 | [The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins]. | 2012 | 10 |
| 9 | 2010 | 27 | |
| 10 | 2010 | 25 | |
| 11 | Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasia. | 2010 | 9 |
| 12 | 2009 | 11 | |
| 13 | 2009 | 82 | |
| 14 | 2008 | 30 | |
| 15 | 2006 | 43 |
About Victoria Wargon
Victoria Wargon is a scholar working on Oncology, Genetics and Toxicology, having authored 15 papers that have together received 471 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (10 papers), Cytokine Signaling Pathways and Interactions (5 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), HER2/EGFR in Cancer Research (2 papers), Bioactive Compounds and Antitumor Agents (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Genetics (238 citations), Oncology (213 citations) and Cancer Research (84 citations). Victoria Wargon has collaborated with scholars based in Argentina, United States and Sweden. Frequent co-authors include Claudia Lanari, Alfredo Molinolo, Sebastián Giulianelli, Paola Rojas, Luísa A. Helguero, Caroline A. Lamb, Rocío Soldati, Alfredo A. Molinolo, Oscar E. Pérez and Ana M.R. Pilosof. Their work appears in journals such as PLoS ONE, Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.